Pretreatment Hemoglobin Level Is an Independent Prognostic Factor in Patients with Lung Adenocarcinoma
Background/Aim. Few studies have reported the prognostic value of pretreatment hemoglobin levels in patients with lung adenocarcinoma (LA). In the present study, we retrospectively reviewed 306 LA patients for their prognosis associated with the pretreatment hemoglobin levels. Methods. Person-years...
Saved in:
Main Authors: | Yue-Hua Zhang, Yuquan Lu, Hong Lu, Meng-Wei Zhang, Yue-Min Zhou, Xiang-Lei Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2018/6328127 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GGT5 Is an Independent Prognostic Biomarker in Stomach Adenocarcinoma
by: Yong Huang, et al.
Published: (2022-01-01) -
The role of LMNB2 as a diagnostic and prognostic biomarker in lung adenocarcinoma
by: Shengshan Xu, et al.
Published: (2025-02-01) -
Characteristics and Prognostic Nomogram for Primary Lung Lepidic Adenocarcinoma
by: Hui Tang, et al.
Published: (2022-01-01) -
Multi-omic and machine learning analysis of mitochondrial RNA modification genes in lung adenocarcinoma for prognostic and therapeutic implications
by: Xiao Zhang, et al.
Published: (2025-03-01) -
Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma
by: Juan Li, et al.
Published: (2022-01-01)